From Molecule to Market

700 Harris Street,Charlottesville VA 22903

31 January, 2023

Description

The CvilleBioHub Monthly Speaker Series for January features short presentations from four companies in the Charlottesville biotech ecosystem at the cutting edge of life sciences innovation, each at different stages of the product development cycle. Featured Speakers AstraZeneca is a global, science-led, patient-focused pharmaceutical company focused on creating genuinely innovative medicines and improving access to them. BrightSpec Molecular Rotational Resonance (MRR) spectrometers enable the unambiguous ID and quantification of molecules and can determine molecular structure even in cases where mass spec or NMR struggle. BrightSpec offers a line of instruments for broadband identification of unknowns to targeted validation or impurity analysis, as well as comprehensive lab services utilizing the unique capabilities of MRR. InBio manufactures a suite of readily available allergen products and testing services that biotech and pharmaceutical companies can use to help bring proprietary materials to market. InBio offers a case study in innovative product development serving an ever-changing market. KeViRx focuses on the development of novel small molecules that target drivers of human cancer and acute lung injury. Its lead compound, KVX-053, is an allosteric PTP4A3 phosphatase small molecule inhibitor in development for oncology and respiratory disorders. Special thanks to our exclusive event sponsor DPR Construction.